Israel Englander Bio N Tech Se Call Options Transaction History

Millennium Management LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$78.36 - $124.66 $407,472 - $648,232	5,200 Added 11.56%	50,200 $5.96 Million
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $747,348 - $956,691	9,300 Added 26.05%	45,000 $3.62 Million
Q1 2024 May 15, 2024	BUY	$88.96 - $112.35 $1.14 Million - $1.44 Million	12,800 Added 55.9%	35,700 $3.29 Million
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $1.64 Million - $2.03 Million	-18,000 Reduced 44.01%	22,900 $2.42 Million
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $3.93 Million - $4.97 Million	38,300 Added 1473.08%	40,900 $4.41 Million
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $318,682 - $399,541	2,600 New	2,600 $324,000

356

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.